Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,638.80
-31.40 (-1.88%)
Sep 11, 2025, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 171.45 billion as of September 11, 2025. Its market cap has increased by 1.61% in one year.
Market Cap
171.45B
Enterprise Value
168.30B
Revenue
11.88B
Ranking
n/a
PE Ratio
48.16
Stock Price
1,638.80
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 171.45B, an increase of 73.82%. That is a compound annual growth rate of 30.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 171.45B | -25.87% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,823.10B |
| Divi's Laboratories | 1,601.17B |
| Cipla | 1,263.17B |
| Apollo Hospitals Enterprise | 1,140.07B |
| Mankind Pharma | 1,076.68B |
| Zydus Lifesciences | 1,046.08B |
| Fortis Healthcare | 730.16B |
| Alkem Laboratories | 644.87B |